(Q39491687)

English

An in vitro comparison of the effects of the iron-chelating agents, CP94 and dexrazoxane, on protoporphyrin IX accumulation for photodynamic therapy and/or fluorescence guided resection

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

An in vitro comparison of the effects of the iron-chelating agents, CP94 and dexrazoxane, on protoporphyrin IX accumulation for photodynamic therapy and/or fluorescence guided resection (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

author name string

Emma Blake

1

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

James Allen

2

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Alison Curnow

3

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

publication date

16 September 2011

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Photochemistry and Photobiology

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

87

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

1419-1426

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Photodynamic therapy in oncology: mechanisms and clinical use.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00985.X

21 January 2018

Differential interaction of porphyrins used in photoradiation therapy with ferrochelatase

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00985.X

21 January 2018

Porphyrin metabolism in some malignant diseases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00985.X

21 January 2018

A regulatory role for porphobilinogen deaminase (PBGD) in delta-aminolaevulinic acid (delta-ALA)-induced photosensitization?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00985.X

21 January 2018

Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00985.X

21 January 2018

Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma: results of a multicenter randomized prospective trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00985.X

21 January 2018

Biochemical manipulation via iron chelation to enhance porphyrin production from porphyrin precursors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00985.X

21 January 2018

Photodynamic therapy of brain tumors--a work in progress

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00985.X

21 January 2018

Computer simulation of glioma growth and morphology

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00985.X

21 January 2018

Photodynamic therapy of human glioma spheroids using 5-aminolevulinic acid.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00985.X

21 January 2018

In vitro and in vivo porphyrin accumulation by C6 glioma cells after exposure to 5-aminolevulinic acid.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00985.X

21 January 2018

The influence of UV exposure on 5-aminolevulinic acid-induced protoporphyrin IX production in skin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00985.X

21 January 2018

Intraoperative detection of malignant gliomas by 5-aminolevulinic acid-induced porphyrin fluorescence

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00985.X

21 January 2018

The efficacy of an iron chelator (CP94) in increasing cellular protoporphyrin IX following intravesical 5-aminolaevulinic acid administration: an in vivo study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00985.X

21 January 2018

The effect of EDTA and serum on endogenous porphyrin accumulation and photodynamic sensitization of human K562 leukemic cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00985.X

21 January 2018

Selective necrosis of malignant gliomas in mice using photodynamic therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00985.X

21 January 2018

Scavenging effects of dexrazoxane on free radicals

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00985.X

21 January 2018

The hydroxypyridinone iron chelator CP94 can enhance PpIX-induced PDT of cultured human glioma cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00985.X

21 January 2018

Enhancement of 5-aminolaevulinic acid-induced photodynamic therapy in normal rat colon using hydroxypyridinone iron-chelating agents

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00985.X

21 January 2018

Clinical investigation of the novel iron-chelating agent, CP94, to enhance topical photodynamic therapy of nodular basal cell carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00985.X

21 January 2018

Selective distribution of porphyrins in skin thick basal cell carcinoma after topical application of methyl 5-aminolevulinate

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00985.X

21 January 2018

The iron(III) and copper(II) complexes of adriamycin promote the hydrolysis of the cardioprotective agent ICRF-187 ((+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00985.X

21 January 2018

Deferoxamine iron chelation increases delta-aminolevulinic acid induced protoporphyrin IX in xenograft glioma model

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00985.X

21 January 2018

Combining etoposide and dexrazoxane synergizes with radiotherapy and improves survival in mice with central nervous system tumors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00985.X

21 January 2018

Bradykinin selectively opens blood-tumor barrier in experimental brain tumors.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00985.X

21 January 2018

Poly(ethylene glycol)-coated hexadecylcyanoacrylate nanospheres display a combined effect for brain tumor targeting

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-1097.2011.00985.X

21 January 2018

Identifiers

10.1111/J.1751-1097.2011.00985.X

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39491687&oldid=1985118272"